# Edoxaban

## Lixiana F.C. 30mg

#### 一般可用

| 藥品代碼       | OLIX                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Deep vein thrombosis and pulmonary embolism: Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant. Nonvalvular atrial fibrillation: To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF)                                                                                                                                                                                                                                                                                      |
| 用法用量       | Prevent stroke and systemic embolism: oral 60mg once daily.  Treatment of DVT and PE: oral 60mg once daily after at least 5 days of parenteral anticoagulant therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 禁忌           | Active pathological bleeding， hypersenstive.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 副作用         | >10%: Hematologic and oncologic: Hemorrhage (22%) 1% to 10%: Dermatologic: Dermal hemorrhage (6%)， skin rash (4%) Gastrointestinal: Gastrointestinal hemorrhage (4%)， lower GI bleeding (3%) Genitourinary: Vaginal hemorrhage (9%)， gross hematuria， urethral bleeding Hematologic and oncologic: Major hemorrhage， nonlife-threatening (7% to 9%; noncritical organ: 1%; critical organ: <1%)， major hemorrhage (1%)， oral hemorrhage (3%)， anemia (2%)， decreased hemoglobin (1%)， puncture site bleeding (1%) Hepatic: Abnormal hepatic function tests (5% to 8%) Respiratory: Epistaxis (5%)， pharyngeal bleeding |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

